Protara Therapeutics, Inc.
TARADrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How TARA's past catalysts played out
Choline Chloride for Injection
Choline Deficiency
TARA-002
Non-muscle Invasive Bladder Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Choline Chloride for Injection | Phase 3 | Choline Deficiency | - | - |
TARA-002 | Phase 2 | Non-muscle Invasive Bladder Cancer | - | - |
Frequently asked questions
What is in Protara Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Protara Therapeutics, Inc.'s (TARA) pipeline across Phase 3, Phase 2. Its lead program is Choline Chloride for Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Protara Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Protara Therapeutics, Inc. (TARA) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TARA biotech catalysts?→
Add TARA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Protara Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.